Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

1.50
Delayed Data
As of May 20
 -0.01 / -0.66%
Today’s Change
1.29
Today|||52-Week Range
8.50
-68.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash29.4M47.7M12.8M22.5M
 
 
 
 
 
Short Term Investment Cash26.7M18.4M-34.9M9.6M
 
 
 
 
 
Cash & Short Term Investments33.1M63.5M50.3M74.5M
 
 
 
 
 
 
ReceivablesReceivables1.7M1.2M3.1M300.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets912.0K1.7M1.6M1.9M
 
 
 
 
 
Current Assets35.8M66.4M55.0M76.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross456.0K839.0K1.3M1.8M
 
 
 
 
 
Depreciation-108.0K-240.0K-487.0K-752.0K
 
 
 
 
 
Other Assets2.6M40.0K232.0K50.0K
 
 
 
 
 
Total Assets38.7M67.1M56.1M77.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable176.0K168.0K389.0K663.0K
 
 
 
 
 
Accrued Expenses1.8M2.5M3.4M6.9M
 
 
 
 
 
Other Current Liabilities1.8M2.5M3.4M6.9M
 
 
 
 
 
Other Liabilities2.5M4.0M5.6M10.2M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities27.0K132.0K111.0K72.0K
 
 
 
 
 
Total Liabilities2.6M4.1M5.7M10.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock58.3M0.000.000.00
 
 
Common Equity-22.2M63.0M50.3M67.4M
 
 
 
 
 
Total Shareholder Equity36.1M63.0M50.3M67.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding13.7M13.4M16.7M24.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.